Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics
Resistell News:

Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Meet Resistell's team at the Swiss Symposium in Point-of-Care Diagnostics and see live presentation of our technology.
Meet Resistell in Davos on 21.10.2021 at the 4th Swiss Symposium in Point-of-Care Diagnostics

Latest news

Resistell featured in HANDELSZEITUNG!
image source: HANDELSZEITUNG | Photo: Christian Aeberhard
4th February 2020

Resistell featured in HANDELSZEITUNG!

Resistell - The EPFL spin-off knows how to find the right medication around 100 times faster. This can significantly increase a patient's chance of survival.
The importance of prototyping in the journey of entrepreneurs
31st January 2020

The importance of prototyping in the journey of entrepreneurs

In their development, start-ups face an important challenge: the creation of a prototype. A crucial step, where many risks have to be overcome and where different skills have to be combined.
Resistell makes it to 10 Swiss Biotech Startups to Watch in 2020
24th January 2020

Resistell makes it to 10 Swiss Biotech Startups to Watch in 2020

Swiss Biotech startups are considered among the most promising and innovative companies in the world. Big industry players have already acquired many Biotech startups and large transactions had a relevant impact on the entire Swiss ecosystem. Discover now 10 Swiss Biotech startups to watch in 2020. The practice of medicine has changed dramatically over the past years and we all know that the healthcare systems are becoming more complex and more expensive. Much of that progress is likely to result from advances in personalized medicine. This new treatment paradigm aims to ensure that patients get the therapies best suited to their specific genetic conditions.
Resistell AG closes CHF 3.5M series A financing round
17th December 2019

Resistell AG closes CHF 3.5M series A financing round

Resistell AG has today closed an oversubscribed series A financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test.
World Antibiotic Awareness Week 2019
18th November 2019

World Antibiotic Awareness Week 2019

The future of antibiotics depends on all of us! Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.